Why the study?
Many commonly used drugs and COVID-19 can prolong the QTc interval, leading to potentially life-threatening arrhythmias, creating a need to evaluate portable single-lead ECG devices against standard 12-lead ECG.
Does a portable single-lead ECG device accurately measure QTc intervals compared to a standard 12-lead ECG in hospitalized patients?
Does a portable single-lead ECG device accurately measure QTc intervals compared to a standard 12-lead ECG in hospitalized patients?
A portable single-lead ECG device provides highly accurate QTc interval measurements compared to standard 12-lead ECGs, offering a simpler alternative for monitoring hospitalized patients.
Answers are grounded in this paper and cite their sources.
Portable single-lead ECG supports convenient QTc monitoring amid COVID therapies; leaves open need for outcome validation before routine adoption.
Background Many commonly used drugs can prolong the QTc interval (QTc), which can lead to potentially life-threatening arrhythmias. In the current era of the COVID-19 pandemic, it is worth mentioning that the disease itself and several drugs used for its treatment have been associated with QTc prolongation. Objective To evaluate the agreement and clinical precision of a portable single-lead electrocardiogram (ECG) device to measure the QTc interval compared to the standard 12-lead ECG. Methods In sequential tests, QTc of ECG recordings obtained with the KardiaMobile (KM-1L) device (AliveCor, San Francisco, CA) were compared to QTc obtained with conventional 12-lead ECG. Agreement was evaluated using Bland-Altman plots and Lin's concordance coefficient. Consistency between the 2 devices in determining QTc prolongation (QTc ≥470 ms in males or ≥480 ms in females) was evaluated with kappa statistics. Results A total of 128 patients with a presumed or confirmed diagnosis of COVID-19 admitted to a university hospital were included. QTc intervals measured with KM-1L were similar to QTc measured with conventional ECG (442.45 ± 40.5 vs 441.65 ± 40.3 ms, P = .15). Bland–Altman analysis showed no significant difference in QTc values (average difference of -0.797, 95% limits of agreement:-13.179; 11.585). Lin's concordance coefficient showed an excellent agreement (0.988, P < .001). Concordance between the 2 devices for determining QTc prolongation was excellent (kappa >0.90). Conclusion ECG recordings obtained with KM-1L allow an accurate QTc interval assessment. Considering its simplicity of use, this approach has advantages over conventional ECG and can provide an alternative for the evaluation of QTc in hospitalized patients, during the current time of the COVID-19 pandemic and beyond.
No takes yet. Share an insight, caveat, or question.
O et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: